Search clinical trials for: Adapalene-Benzoyl Peroxide Gel 0.1-2.5%

Total 156 results

Galderma R&D

Completed

Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Epiduo Pediatric Acne Study

Acne

United States, Canada
Galderma R&D

Completed

Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris.

Acne Vulgaris

Japan
Galderma R&D

Completed

Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes

P Acnes Colonization

United States
Galderma R&D

Completed

Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne

Acne

United States
Mahidol University

Withdrawn

A Study of Efficacy of Benzoyl Peroxide Regimens in Treatment of Unpleasant Foot Odor

Foot Dermatoses | Benzoyl Peroxide

Thailand
Galderma R&D

Completed

Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance (ACCESS II)

Acne

United States, Canada, Puerto Rico
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris

Acne Vulgaris
Galderma R&D

Completed

Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Galderma R&D

Completed

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Acne

United States
Actavis Mid-Atlantic LLC

Completed

A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris

Acne Vulgaris

United States, Belize, India
Derm Research, PLLC

Completed

The Use of Oracea and Epiduo Forte in Severe Acne Patients

Acne

United States
Merete Haedersdal
Sebacia, Inc.

Completed

Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery

Acne Vulgaris | Microparticles

Denmark
Padagis LLC

Completed

Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris

Acne
Galderma R&D

Completed

A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne

Acne Vulgaris

United States
Actavis Inc.

Completed

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

Acne

United States, Belize
Galderma Laboratorium GmbH

Completed

Efficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory Acne (TEENA)

Acne
Galderma Laboratorium GmbH

Completed

Long-term Study of Epiduo in Patients With Moderate to Severe Acne (ELANG)

Acne Vulgaris
Galderma Laboratorium GmbH

Completed

Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne (PUMP-it)

Acne Vulgaris
Galderma R&D

Completed

Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.

Acne Vulgaris

Japan
Wake Forest University
Galderma R&D

Completed

Effect of Samples on Acne Treatment With Epiduo® Gel

Acne Vulgaris

United States
Bausch Health Americas, Inc.

Completed

Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face

Acne Vulgaris

United States
Galderma R&D

Completed

A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Germany, Canada, Hungary, Poland
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

Acne Vulgaris

United States
Chulalongkorn University

Completed

2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne

Acne Vulgaris

Thailand
NYU Langone Health

Withdrawn

The Comparative Efficacy of an Over the Counter Light Therapy Mask vs Over the Counter Topical Benzoyl Peroxide 2.5% and Used in Combination With Over the Counter Adapalene Gel 0.1% for Mild to Moderate Acne

Acne
Galderma R&D

Completed

A Treatment for Severe Inflammatory Acne Subjects

Acne Vulgaris

United States
University of Oklahoma

Withdrawn

MC RCT - BPO vs Adapalene

Molluscum Contagiosum

United States
Wake Forest University Health Sciences
Bausch Health Americas, Inc.

Not yet recruiting

Experience With Topical Acne Treatment

Acne

United States
Galderma R&D

Completed

Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects

Acne Vulgaris

United States
GlaxoSmithKline

Completed

Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects

Acne Vulgaris

Japan
Watson Laboratories, Inc.

Completed

Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

Acne Vulgaris
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris (Narciso)

Acne Vulgaris
Wake Forest University

Completed

A Novel Method to Improve Acne Outcomes

Acne Vulgaris

United States
Cosmetique Active International

Completed

Efficacy and Tolerance of Formula 609613 37 in Acneic Patients

Acne
Galderma R&D

Completed

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Padagis LLC

Completed

A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris

Acne
Colorado Joint Replacement

Recruiting

Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

Degenerative Osteoarthritis

United States
Galderma R&D

Completed

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

Acne Vulgaris

United States, Canada
Padagis LLC

Completed

Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face

Acne Vulgaris

United States
Galderma R&D

Completed

A Long Term Study of GK530G in Subjects With Acne Vulgaris

Acne Vulgaris

Japan
East Avenue Medical Center, Philippines

Completed

Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients

Acne Vulgaris

Philippines
Claret Medical
Meditrial Europe Ltd.

Completed

Carotid Filtration During Endovascular Aortic Valve Implantation

Heart Diseases
Galderma R&D

Completed

A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

Acne

Canada, France
Bausch Health Americas, Inc.

Completed

Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face

Acne Vulgaris

United States
Yardley Dermatology Associates
Topix Pharmaceuticals, Inc

Terminated

The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol

Acne Vulgaris

United States
Allergan

Completed

A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%

Acne Vulgaris

3

Subscribe